What Is Elutia, Inc. (ELUT) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Elutia, Inc.'s intrinsic value is estimated at a composite fair value of $1.14. Trading at $0.96, the stock is approaching fair value or slight overvaluation (implied return of +18.8%), as 7 of 11 models suggest limited further upside. Model dispersion is worth noting: FTNN targets $5.54 (+476.7%), versus ML-RIV at $0.06 (-93.9%). This +570.6% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About ELUT?
11 of 13 models are currently active for ELUT. Of these, 4 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates ELUT's intrinsic value at $0.31, implying -67.9% downside from the current price. See which stocks rank higher →
How Does ELUT Rank in Biological Products, (No Diagnostic Substances)?
Among 134 Biological Products, (No Diagnostic Substances) stocks, ELUT ranks #76 by Quality of Company score. CirclFi's QOC score of 5.0/10 evaluates 32 fundamental signals. A score of 5.0 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Elutia, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is ELUT a Value Trap?
CirclFi's Value Trap algorithm assigns ELUT a score of 44/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for Elutia, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Elutia, Inc. scores 5.0 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +570.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ELUT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ELUT's 11 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad